Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Norwegian (OSEAX) Biotech Industry Analysis

UpdatedDec 24, 2025
DataAggregated Company Financials
Companies9
  • 7D11.3%
  • 3M19.6%
  • 1Y34.7%
  • YTD22.9%

In the last week, the Biotech industry is up 7.6%, with Thor Medical up 15%. In the same time, Nykode Therapeutics was down 5.3%. In the last 12 months, the industry was up 31%. As for the next few years, earnings are expected to grow by 29% per annum.

Industry Valuation and Performance

Has the Norwegian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 24 Dec 2025NOK 5.4bNOK 606.9m-NOK 367,972,507.5279.4x-14.6x8.9x
Fri, 21 Nov 2025NOK 4.3bNOK 241.7m-NOK 557,545,994.79162.4x-7.7x17.8x
Sun, 19 Oct 2025NOK 5.0bNOK 612.3m-NOK 518,776,394.63265.8x-9.6x8.1x
Tue, 16 Sep 2025NOK 4.8bNOK 610.5m-NOK 495,104,453.23232.1x-9.7x7.9x
Thu, 14 Aug 2025NOK 4.8bNOK 886.0m-NOK 747,531,553.67225.3x-6.4x5.4x
Sat, 12 Jul 2025NOK 4.7bNOK 884.9m-NOK 744,220,579.71193.8x-6.3x5.3x
Mon, 09 Jun 2025NOK 4.7bNOK 885.2m-NOK 745,181,005.24188.6x-6.3x5.3x
Wed, 07 May 2025NOK 4.8bNOK 518.3m-NOK 1,014,332,846.79114x-4.7x9.2x
Fri, 04 Apr 2025NOK 4.4bNOK 518.9m-NOK 912,620,074.21109x-4.8x8.4x
Sun, 02 Mar 2025NOK 5.0bNOK 527.4m-NOK 1,125,854,210.91123.8x-4.4x9.5x
Tue, 28 Jan 2025NOK 4.9bNOK 457.2m-NOK 1,069,851,873.52154.5x-4.5x10.6x
Thu, 26 Dec 2024NOK 4.6bNOK 457.5m-NOK 1,072,737,063.80147.9x-4.2x10x
Sat, 23 Nov 2024NOK 4.4bNOK 480.4m-NOK 1,070,042,692.05146.8x-4.1x9.1x
Mon, 21 Oct 2024NOK 4.8bNOK 471.9m-NOK 1,069,688,381.8058.7x-4.5x10.2x
Wed, 18 Sep 2024NOK 5.2bNOK 469.8m-NOK 1,050,859,997.6561.3x-5x11.2x
Fri, 16 Aug 2024NOK 8.2bNOK 514.9m-NOK 1,045,953,065.6869.7x-7.8x15.9x
Sun, 14 Jul 2024NOK 8.9bNOK 514.7m-NOK 1,044,942,156.4067.2x-8.5x17.3x
Tue, 11 Jun 2024NOK 9.5bNOK 641.8m-NOK 941,809,275.2838x-10.1x14.8x
Thu, 09 May 2024NOK 8.5bNOK 658.8m-NOK 958,463,456.7833.3x-8.9x12.9x
Sat, 06 Apr 2024NOK 8.8bNOK 656.9m-NOK 939,896,283.5239.4x-9.4x13.4x
Mon, 04 Mar 2024NOK 14.5bNOK 659.5m-NOK 921,184,513.7642.2x-15.8x22x
Wed, 31 Jan 2024NOK 16.3bNOK 656.2m-NOK 1,358,395,863.0059.8x-12x24.8x
Fri, 29 Dec 2023NOK 16.7bNOK 652.4m-NOK 1,347,239,442.0061.3x-12.4x25.6x
Sun, 26 Nov 2023NOK 15.6bNOK 660.1m-NOK 1,369,621,200.0059.5x-11.4x23.6x
Tue, 24 Oct 2023NOK 14.4bNOK 490.0m-NOK 1,554,504,857.0094.9x-9.3x29.4x
Thu, 21 Sep 2023NOK 16.1bNOK 624.5m-NOK 1,459,336,924.0054.3x-11x25.7x
Sat, 19 Aug 2023NOK 15.7bNOK 558.3m-NOK 1,477,033,869.0061.5x-10.6x28.1x
Mon, 17 Jul 2023NOK 15.6bNOK 553.9m-NOK 1,447,285,150.0058.1x-10.8x28.3x
Wed, 14 Jun 2023NOK 16.2bNOK 560.7m-NOK 1,483,828,700.0064.5x-10.9x28.9x
Fri, 12 May 2023NOK 16.6bNOK 541.4m-NOK 1,441,799,116.0030.7x-11.5x30.6x
Sun, 09 Apr 2023NOK 16.0bNOK 549.5m-NOK 1,549,007,171.0032.1x-10.3x29.1x
Tue, 07 Mar 2023NOK 17.1bNOK 535.8m-NOK 1,676,551,093.0029.5x-10.2x32x
Thu, 02 Feb 2023NOK 18.5bNOK 812.4m-NOK 1,396,065,221.0025x-13.2x22.8x
Sat, 31 Dec 2022NOK 19.0bNOK 804.9m-NOK 1,392,096,004.0039.4x-13.7x23.7x
Price to Earnings Ratio

-13.7x


Total Market Cap: NOK 19.0bTotal Earnings: -NOK 1,392,096,004.00Total Revenue: NOK 804.9mTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Biotech Industry Price to Earnings3Y Average -8.8x202320242025
Current Industry PE
  • Investors are pessimistic on the Norwegian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 16.6x is higher than the industry's current PS ratio of 8.7x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 9.1% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market1.89%
Healthcare5.02%
Biotech11.34%
Biotech11.34%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TRMED Thor MedicalNOK 5.1522.0%
+NOK 329.3m		93.6%PS18235x
NORD NordaNOK 100.0021.7%
+NOK 91.3m		25.0%PE4.1x
ZLNA ZellunaNOK 14.7031.3%
+NOK 71.6m		n/aPS5673.1x
AZT ArcticZymes TechnologiesNOK 21.805.8%
+NOK 61.3m		62.7%PE154.6x
NYKD Nykode TherapeuticsNOK 2.340.8%
+NOK 5.9m		-22.5%PS10.3x

Latest News

AZT
NOK 21.80
ArcticZymes Technologies
7D
5.8%
1Y
62.7%

AZT: European Distribution Deal And Buyback Program Will Drive Future Upside

Analysts have modestly raised their price target on ArcticZymes Technologies to NOK 32.00, reflecting slightly lower perceived risk and continued confidence in the company’s robust growth and margin profile. What's in the News ArcticZymes Technologies has commenced a share repurchase program starting November 25, 2025, allowing buybacks of up to 2,500,000 shares, or 4.90 percent of outstanding share capital.
ABS
NOK 3.24
Arctic Bioscience
7D
-11.5%
1Y
69.6%
ZLNA
NOK 14.70
Zelluna
7D
31.3%
1Y
n/a
LYTIX
NOK 9.88
Lytix Biopharma
7D
0.8%
1Y
65.8%

Here's Why We're Not Too Worried About Lytix Biopharma's (OB:LYTIX) Cash Burn Situation

Dec 15
Here's Why We're Not Too Worried About Lytix Biopharma's (OB:LYTIX) Cash Burn Situation
CRNA
NOK 1.18
Circio Holding
7D
-1.2%
1Y
62.4%
NYKD
NOK 2.34
Nykode Therapeutics
7D
0.8%
1Y
-22.5%
TRMED
NOK 5.15
Thor Medical
7D
22.0%
1Y
93.6%
PCIB
NOK 0.25
PCI Biotech Holding
7D
-7.4%
1Y
-80.8%
EXTX
NOK 1.47
EXACT Therapeutics
7D
-5.2%
1Y
-61.1%
NORD
NOK 100.00
Norda
7D
21.7%
1Y
25.0%